V Square Quantitative Management LLC Exelixis, Inc. Transaction History
V Square Quantitative Management LLC
- $747 Billion
- Q2 2025
A detailed history of V Square Quantitative Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, V Square Quantitative Management LLC holds 741 shares of EXEL stock, worth $27,950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
741
Previous 1,563
52.59%
Holding current value
$27,950
Previous $57.7 Million
43.4%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding EXEL
# of Institutions
658Shares Held
255MCall Options Held
1.67MPut Options Held
733K-
Black Rock Inc. New York, NY33.5MShares$1.26 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.08 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$850 Million4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$559 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$445 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.1B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...